nach oben

Cancer and Metastasis Reviews

Erschienen in:

01.06.2012 | NON-THEMATIC REVIEW

Role of parathymic lymph nodes in metastatic tumor development

verfasst von: Gaspar Banfalvi

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 1-2/2012

Einloggen, um Zugang zu erhalten

Abstract

Parathymic lymph nodes as potential sites of tumor progression have been neglected in humans. We have established a rat renal capsule–parathymic lymph node model to study in vivo metastasis. Epithelial liver carcinoma (HeDe) and mesenchymal mesoblastic nephroma (NeDe) cell lines have been established after inducing chemical carcinogenesis in newborn Fisher 344 inbred rats by N-nitrosodimethylamine. Implanting the exact number of tumor cells (HeDe, NeDe) under the renal capsule allowed the standardization and timing of metastatic development. Tumor cells released from the primary tumor in the peritoneal cavity were drained to the parathymic lymph nodes (PTNs) as sentinel lymph nodes. Similarly, tumor cells injected i.p. were engulfed by macrophages, drained through the transdiaphragmatic channels, and transported to the thoracal lymphatics, primarily to PTNs. Tumor cells after transdiaphragmic drainage can enter both anterior mammary and parathymic sentinel lymph nodes. The potential common origin can shed new light on the metastatic cell progression of PTNs and mammary tumors.

Macchiarini, P., & Ostertag, H. (2004). Uncommon primary mediastinal tumours. The Lancet Oncology, 5, 107–118.PubMedCrossRef

Davis, R. D., Oldham, H. N., & Sabiston, D. C. (1987). Primary cysts and neoplasms of the mediastinum: Recent changes in clinical presentation, methods of diagnosis, management, and results. The Annals of Thoracic Surgery, 44, 229–237.PubMedCrossRef

Den Bakker, M. A., & Oosterhuis, J. W. (2009). Tumours and tumour-like conditions of the thymus other than thymoma: A practical approach. Histopathology, 54, 69–89.CrossRef

Sachithanandan, A., Badmanaban, B., Graham, A., & O’Kane, H. (2002). Malignant internal mammary lymph nodes during mobilization of the internal mammary artery. The European Journal of Cardio-thoracic Surgery, 22, 5847–5848.

Chambers, A. A., Cado, D., Truong, T., & Allison, J. P. (1997). Thymocyte development is normal in CTLA-4-deficient mice. Proceedings of the National Academy of Sciences USA, 94, 296–9301.CrossRef

Mishell, B. B., & Shiigii, S. M. (1980). Selected methods in cellular immunology (pp. 8–9). San Francisco: Freeman.

Blau, J. N., & Gaugas, J. M. (1968). Parathymic lymph nodes in rats and mice. Immunology, 14, 763–765.PubMed

Takahashi, S., & Patrick, G. (1987). Pattern of lymphatic drainage to individual thoracic and cervical lymph nodes in the rat. Laboratory Animals, 21, 31–34.PubMedCrossRef

Tilney, N. L. (1971). Patterns of lymphatic drainage in the adult laboratory rat. Journal of Anatomy, 109, 369–383.PubMed

10.

Dunn, T. B. (1954). Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. Journal of the National Cancer Institute, 14, 1281–1433.PubMed

11.

Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., et al. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 270, 985–988.PubMedCrossRef

12.

Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3, 541–546.PubMedCrossRef

13.

Yamashita, A., Miyasaka, M., & Trnka, Z. (1985). Early post- thymic T cells: Studies on lymphocytes in the lymph coming from thymus of the sheep. In B. Morris & M. Miyasaka (Eds.), Immunology of the sheep (p. 162). Basel: Editions Roche.

14.

Harris, P. F., & Templeton, W. R. (1966). Preliminary studies on the lymphatic drainage of the guinea-pig thymus with special reference to extrinsic vessels. Journal of Anatomy London, 100, 694.

15.

Severeanu, G. Die Lymphgefäße der Thymus. Arch Anat Entw Gesch 1909, 93.

16.

Tanegashima, A., Yamashita, A., Yamamoto, H., & Fukunaga, T. (1999). Human parathymic lymph node: Morphological and functional significance. Immunology, 97, 301–308.PubMedCrossRef

17.

Finger, H., Heymer, B., Emmerling, P., & Hof, H. (1977). Antibody-forming potential of lymph nodes in aged mice, with special reference to the influence of adjuvant. Gerontology, 23, 185–204.PubMedCrossRef

18.

Pitt, M. L. M., & Anderson, A. O. (1988). Direct transdiaphragmatic traffic of peritoneal macrophages to the lung. In S. Sigbjorn & B. Rolstad (Eds.), Histopathology of the immune system (pp. 627–632). New York: Plenum.

19.

Marco, A. J., Domingo, M., Ruberte, J., Carretero, A., Briones, V., & Dominguez, L. (1992). Lymphatic drainage of Listeria inonocytogenes and Indian ink inoculated in the peritoneal cavity of the mouse. Laboratory Animals, 26, 200–205.PubMedCrossRef

20.

Steer, H. W., & Lewis, D. A. (1983). Cell responses to acute gastrointestinal inflammation. The Journal of Pathology, 140, 237–253.PubMedCrossRef

21.

Roca, M., Balasch, M., Segalés, J., Calsamiglia, M., Viaplana, E., Urniza, A., et al. (2004). In vitro and in vivo characterization of an infectious clone of a European strain of porcine circovirus type 2. Journal of General Virology, 85, 1259–1266.PubMedCrossRef

22.

Esato, K., Kaku, R., & Yamaki, R. (1975). Reevaluation of parasternal lymph node dissection in the treatment of mammary cancer. The Japanese Journal of Surgery, 5, 139–144.PubMedCrossRef

23.

Kamperdijk, E. W. A., van den Berg, M., & Hoefsmit, E. C. M. (1984). Lymph node accessory cells in the immune response. The primary response to paratyphoid vaccine in rat parathymic lymph nodes. Cell and Tissue Research, 237, 39–42.PubMedCrossRef

24.

James, T. N. (1983). Thrombi in antrum atrii dextri of human heart as clinically important source for microembolisation to lungs. British Heart Journal, 49, 122–132.PubMedCrossRef

25.

Banfalvi, G., & Cernay, L. (1975). Factors influencing the formation of ^113mIn–Fe(OH)₃ macroaggregates. Acta Pharmaceutica Hungarica, 45, 215–221.PubMed

26.

Arras, M., Strasser, R., Mohri, M., Doll, R., Eckert, P., Schaper, W., et al. (1998). Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Research in Cardiology, 93, 97–107.PubMedCrossRef

27.

Banfalvi, G., Pal, I., & Csernay, L. (1972). Production of ^113mIn-colloid suitable for liver-scintigraphy. Acta Pharmaceutica Hungarica, 42, 25–32.PubMed

28.

Parragh, G., Foris, G., Paragh, G., Jr., Seres, I., Karanyi, Z., Fulop, P., et al. (2005). Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats. Cancer Letters, 222, 17–22.CrossRef

29.

Trencsenyi, G., Kertai, P., Somogyi, C., Nagy, G., Dombradi, Z., Gacsi, M., et al. (2007). Chemically induced carcinogenesis affecting chromatin structure in rat hepatocarcinoma cells. DNA and Cell Biology, 26, 649–655.PubMedCrossRef

30.

Trencsenyi, G., Kertai, P., Bako, F., Hunyadi, J., Marian, T., Hargitai, Z., et al. (2009). Renal capsule. Parathymic lymph node complex: A new in vivo metastatic model in rats. Anticancer Research, 29, 2121–2126.PubMed

31.

Trencsenyi, G., Juhasz, T., Bako, F., Marian, T., Pocsi, I., Kertai, P., et al. (2010). Comparison of the tumorigenic potential of liver and kidney tumors induced by N-nitrosodimethylamine. Histology and Histopathology, 25, 309–320.PubMed

32.

Rozsa, D., Trencsenyi, G., Kertai, P., Marian, T., Nagy, G., & Banfalvi, G. (2009). Lymphatic spread of mesenchymal renal tumor to metastatic parathymic lymph nodes. Histology and Histopathology, 24, 1367–1379.PubMed

33.

Steer, H. W., & Foot, R. A. (1987). Changes in the medulla of the parathymic lymph nodes of the rat during acute gastro-intestinal inflammation. Journal of Anatomy, 152, 23–36.PubMed

34.

Manville, L. J., & Ane, J. N. (1932). A Roentgen-ray study in absorption of thorium dioxide from peritoneal cavity of albino rat. Proceedings of the Society for Experimental Biology and Medicine, 30, 28–30.

35.

Zhdanov, D. A. (1952). General anatomy and physiology of the lymphatic system. Leningrad: Medgiz.

36.

Olin, T., & Saldeen, T. (1964). The lymphatic pathways from the peritoneal cavity: A lymphangiographic study in the rat. Cancer Research, 24, 1700–1711.PubMed

37.

Williams, L., & Warwick, R. (Eds.). (1980). Gray’s anatomy (36th ed., p. 377). London: Churchill-Livingstone.

38.

Sapin, M. R., & Shvedavchenko, A. I. (1981). Anatomy and topography of the parasternal lymph nodes in the adult. Voprosy Onkologii, 27, 66–70 (in Russian).PubMed

39.

Drinker, C. K., Field, M. E., & Ward, H. K. (1934). The filtering capacity of lymph nodes. The Journal of Experimental Medicine, 59, 393–405.PubMedCrossRef

40.

Widdicombe, J. G., Hughes, R., & May, A. J. (1955). The efficiency of filtration by the popliteal lymph node of the rabbit. British Journal of Experimental Pathology, 36, 473–478.PubMed

41.

Durham, H. E. (1986). The mechanism of reactions to peritoneal infection. Journal of Pathology and Bacteriology, 4, 338–382.CrossRef

42.

Fisher, B., Wolmark, N., Redmond, C., Deutsch, M., & Fisher, E. R. (1981). Findings from NSABP protocol no. B-04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer, 48, 1863–1872.PubMedCrossRef

43.

Menard, S., Bufalino, R., Rilke, F., Cascinelli, N., Veronesi, U., & Colnaghi, M. I. (1994). Prognosis based on primary breast carcinoma instead of pathological nodal status. British Journal of Cancer, 70, 709–712.PubMedCrossRef

44.

Braun, S., Pantel, K., Muller, P., Janni, W., Hepp, F., & Kentenich, C. R. M. (2000). Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. The New England Journal of Medicine, 342, 525–533.PubMedCrossRef

45.

Kato, T., Kameoka, S., Kimura, T., Nishikawa, T., & Kobayashi, M. (2003). The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. British Journal of Cancer, 88, 1900–1908.PubMedCrossRef

46.

Thor, A. D., Moore, D. H., II, Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., et al. (1992). Accumulation of p53 tumour suppressor gene protein: An independent marker of prognosis in breast cancers. Journal of the National Cancer Institute, 84, 1845–1855.

47.

Gilchrist, K. W., Gray, R., Fowble, B., Tormey, D. C., & Taylor, S. G., 4th. (1993). Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: A 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. Journal of Clinical Oncology, 11, 1929–1935.PubMed

48.

Zhang, G. J., Kimijima, I., Abe, R., Watanabe, T., Kanno, M., Hara, K., et al. (1998). Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Research, 18, 1989–1998.PubMed

49.

Kato, T., Kimura, T., Miyakawa, R., Nobue, I., Fujii, A., Yamamoto, K., et al. (1999). The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer. Breast Cancer Research and Treatment, 53, 19–31.PubMedCrossRef

50.

Beenken, S. W., Grizzle, W. E., & Crowe, D. R. (2001). Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53. Annals of Surgery, 233, 630–638.PubMedCrossRef

51.

Sirvent, J. J., Fortuno-Mar, A., Olona, M., & Orti, A. (2001). Prognostic value of p53 protein expression and clinicopathological factors in infiltrating ductal carcinoma of the breast. A study of 192 patients. Histology and Histopathology, 16, 99–106.PubMed

52.

Liu, T. J., Wang, S. J., & Tsai, S. C. (2000). Lymphoscintigraphy using larger colloid particles may enhance visualization of the sentinel node in breast cancer: A case report. Clinical Nuclear Medicine, 25, 191–192.PubMedCrossRef

53.

De Cicco, C., Cremonesi, M., Luini, A., Bartolomei, M., Grana, C., Prisco, G., et al. (1998). Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. Journal of Nuclear Medicine, 39, 2080–2084.PubMed

54.

Mirzaei, S., Knoll, P., Hoffmann, B., Kreuzer, W., & Kohn, H. (2001). Optimized mammary lymphoscintigraphy using larger colloid particles. Journal of Nuclear Medicine, 42, 826.PubMed

55.

Wilhem, A. J., Mijnhout, S., & Franssen, E. J. F. (1999). Radiopharmaceuticals in sentinel lymph-node detection: An overview. European Journal of Nuclear Medicine, 26(Suppl), S36–S42.

56.

Olmos, R. V., Hoefnagel, C., & Nieweg, O. (2001). Optimized mammary lymphoscintigraphy using larger colloid particles. Journal Nuclear Medicine, 42, 826.

57.

Raharison, F., & Sautet, J. (2006). Lymph drainage of the mammary glands in female cats. Journal of Morphology, 267, 292–299.PubMedCrossRef

58.

Weinberg, J. A. (1972). The intrathoracic lymphatics. In C. D. Haagensen (Ed.), The lymphatics in cancer (pp. 231–299). Philadelphia: Saunders.

59.

Sun, Q.-L., Charyulu, V., Lobo, D., & Lopez, D. M. (2002). Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice. Anticancer Research, 22, 91–96.PubMed

60.

Ben-Hur, H., Kossoy, G., Lifschitz, O., & Zusman, I. (2002). Splenectomy, chemically-induced mammary tumors and parathymic lymph nodes in rats: Experimental and morphological studies. In Vivo, 16, 275–280.PubMed

Titel: Role of parathymic lymph nodes in metastatic tumor development
verfasst von: Gaspar Banfalvi
Publikationsdatum: 01.06.2012
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 1-2/2012
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-011-9331-y

Springer Medizin

Role of parathymic lymph nodes in metastatic tumor development

Abstract

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1-2/2012

Discoidin domain receptor tyrosine kinases: new players in cancer progression

Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism

Role of the ubiquitin ligase Fbw7 in cancer progression

Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis

Regulation of p53 by ING family members in suppression of tumor initiation and progression

Cancer stem cells and EMT in carcinoma

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie